-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Faeth Therapeutics, Maintains $55 Price Target

Benzinga·10/27/2026 09:47:55
Listen to the news
BTIG analyst Jeet Mukherjee reiterates Faeth Therapeutics (NASDAQ:FTH) with a Buy and maintains $55 price target.